SPP100 (Rasilez): Pooled Data Analysis Confirms Efficacy And Safety In Over 7000 Hypertensive Patients Treated With First-in-Class Renin Inhibitor

... Speedel (SWX: SPPN) welcomes the pooled analysis of positive Phase II/IIIdata on SPP100 (Rasilez(1)) in the treatment of hypertension both asmonotherapy and in co-administration with other anti-hypertensives. Thisfirst pooled analysis was presented today by Novartis, at the WorldCongress of Cardiology (WCC) in Barcelona. [click link for full article] ...